Gene · 4131
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects. | Mol Neurobiol | 2023 | 37118325 | PubTator, text mining | PubMed |
| Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression. | Int J Mol Sci | 2023 | 37108678 | PubTator, text mining | PubMed |
| Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders. | Int J Mol Sci | 2023 | 37108467 | PubTator, text mining | PubMed |
| Potential Molecular Mechanisms of Alzheimer's Disease from Genetic Studies. | Biology (Basel) | 2023 | 37106802 | PubTator, text mining | PubMed |
| Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation. | Biology (Basel) | 2023 | 37106761 | PubTator, text mining | PubMed |
| Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. | Front Oncol | 2023 | 37091151 | PubTator, text mining | PubMed |
| Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology. | Ann Transl Med | 2023 | 37090052 | PubTator, text mining | PubMed |
| Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. | Nat Commun | 2023 | 37085492 | PubTator, text mining | PubMed |
| Anti-SOX1 antibodies-positive paraneoplastic neurological syndromes caused by thyroid carcinoma: A case report. | Medicine (Baltimore) | 2023 | 37083806 | PubTator, text mining | PubMed |
| Investigating miR-9 as a mediator in laryngeal cancer health disparities. | Front Oncol | 2023 | 37081981 | PubTator, text mining | PubMed |
| The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. | Theranostics | 2023 | 37064875 | PubTator, text mining | PubMed |
| Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer. | Front Oncol | 2023 | 37064116 | PubTator, text mining | PubMed |
| Pleiotropic loci for cannabis use disorder severity in multi-ancestry high-risk populations. | Mol Cell Neurosci | 2023 | 37061172 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer. | Int J Immunopathol Pharmacol | 2023 | 37011378 | PubTator, text mining | PubMed |
| Neurological, Psychiatric, and Multisystemic Involvement of Fragile X Syndrome Along With Its Pathophysiology, Methods of Screening, and Current Treatment Modalities. | Cureus | 2023 | 37007359 | PubTator, text mining | PubMed |
| Modic type 2 changes are fibroinflammatory changes with complement system involvement adjacent to degenerated vertebral endplates. | JOR Spine | 2023 | 36994463 | PubTator, text mining | PubMed |
| High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders. | Genes (Basel) | 2023 | 36980980 | PubTator, text mining | PubMed |
| The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries. | Cancers (Basel) | 2023 | 36980598 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. | J Transl Med | 2023 | 36973787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4131/papers?page=9